Belsomra and Ambien are both prescription sleep medications, but they work in fundamentally different ways inside the brain. While both are classified as Schedule IV controlled substances and are prescribed for insomnia, they belong to entirely different drug classes, produce different types of sleep, and carry different risk profiles. Choosing between them isn’t a matter of picking a stronger or weaker version of the same thing.
How They Work in the Brain
This is the biggest difference between the two, and it shapes everything else about how they compare.
Ambien (zolpidem) is a “Z-drug” that works on the same brain receptors as benzodiazepines like Valium. It enhances the effect of GABA, the brain’s main calming chemical. When GABA activates its receptor, it allows chloride ions to flow into nerve cells, making those neurons less likely to fire. Ambien makes this process happen more frequently, essentially dialing down brain activity across the board. It sedates you into sleep.
Belsomra (suvorexant) takes the opposite approach. Instead of sedating the brain, it blocks orexin, a chemical that keeps you awake. Your brain naturally produces orexin during the day to maintain alertness, and orexin levels drop when it’s time to sleep. Belsomra accelerates that process by blocking orexin receptors, removing the “stay awake” signal rather than forcing a “go to sleep” signal. Think of it this way: Ambien pushes you into sleep, while Belsomra removes the barrier keeping you awake.
Different Effects on Sleep Quality
Because these drugs act on different brain systems, they produce noticeably different kinds of sleep. A head-to-head study in healthy adults measuring brain wave activity during sleep found that zolpidem reduced electrical activity across key frequency bands during both deep sleep and REM sleep. That means Ambien doesn’t just knock you out; it changes the character of your sleep at a measurable level.
Belsomra, by contrast, had little effect on brain wave activity during deep sleep and modestly increased activity during REM sleep. Research shows that orexin-blocking drugs like Belsomra increase total sleep time primarily by promoting REM sleep. REM is the stage associated with dreaming, memory processing, and emotional regulation. This distinction matters if you’ve taken Ambien and felt like you slept but didn’t feel truly rested, or if you’ve noticed your dreams disappeared entirely on the medication.
Side Effects Worth Knowing
Both drugs cause drowsiness, but the specific side effect patterns diverge from there. Ambien is more strongly associated with complex sleep behaviors like sleepwalking (reported by roughly 4.4% of users in reviews), hallucinations (about 3.7%), memory problems, and behavioral changes. The “Ambien sleepwalking” phenomenon, where people eat, drive, or have conversations with no memory of doing so, is well documented and directly tied to how the drug suppresses brain activity.
Belsomra’s side effect profile leans more toward next-day grogginess. Drowsiness is its most commonly reported issue (about 7.9% of users), along with tiredness. Less common effects include sleep paralysis, vivid or abnormal dreams, and hallucinations. The vivid dreams make sense given that Belsomra promotes more REM sleep. Both drugs can worsen existing complex sleep disorders like sleepwalking.
Dependence and Withdrawal Risk
Both medications are Schedule IV controlled substances, meaning the government considers them to have some potential for misuse. But in practice, the risk is not equal. Ambien acts on the same receptor system as benzodiazepines, and it carries a real risk of physical dependence with regular use. Stopping Ambien abruptly after extended use can cause rebound insomnia, where sleep problems temporarily become worse than they were before you started the medication. Some people also experience withdrawal symptoms.
Belsomra’s mechanism of blocking wakefulness signals rather than sedating the brain gives it a generally lower dependence profile. It doesn’t tap into the same reward pathways that make GABA-targeting drugs habit-forming. That said, “lower risk” is not “no risk,” and it’s still a controlled substance for a reason.
How You Take Them
The dosing window is similar for both. Belsomra’s recommended starting dose is 10 mg, with a maximum of 20 mg per night. You take it within 30 minutes of bedtime, and you need at least 7 hours remaining before you plan to wake up. That 7-hour window is important because Belsomra has a relatively long half-life, and taking it too late increases the chance of morning grogginess.
Ambien comes in 5 mg and 10 mg doses, with lower doses recommended for women and older adults because the drug clears more slowly in those groups. The FDA specifically lowered its recommended doses for women in 2013 after concerns about next-morning impairment, particularly with the extended-release version.
One practical note: if you take Belsomra with or right after a heavy meal, absorption slows down and the drug takes longer to work. Taking it on an empty stomach or after a light snack gets it into your system faster. Certain medications that affect liver enzymes can also change how your body processes Belsomra, potentially requiring a lower dose of 5 mg.
Which One Might Suit You Better
If your main problem is falling asleep, Ambien’s faster, more forceful sedation tends to work well for that. It hits hard and wears off relatively quickly, especially the immediate-release version. It’s often prescribed for short-term use, a few weeks at most, because of dependence concerns.
If your problem is staying asleep, or if you’ve had issues with sleepwalking, memory gaps, or next-day confusion on Ambien, Belsomra’s gentler mechanism may be a better fit. It’s also generally considered more appropriate for longer-term use because of its lower dependence potential. The trade-off is that some people find it less potent, particularly those accustomed to the strong sedation of GABA-targeting drugs.
People switching from Ambien to Belsomra sometimes describe the experience as more like “natural” sleep, with more dreaming and an easier time waking up if needed during the night. Others find it simply doesn’t work as powerfully. The two drugs are different enough that responding well to one doesn’t predict how you’ll respond to the other.